Judge won't delay his order for easy access to 'morning after' pill
A federal judge, in a slap to the Obama administration, refused Friday to postpone his order to make the 'morning after' pill widely available to women and girls. The government had sought a stay pending appeal.
A federal judge on Friday refused to significantly delay his order that the morning-after emergency contraception pill be made widely available to women and girls regardless of their age.
US District Judge Edward Korman rejected an Obama administration request that the decision be put on hold while government lawyers present the issue to a federal appeals court panel.
“The motion for a stay pending appeal is denied,” Judge Korman said in a 17-page order. “Indeed, in my view, the [government’s] appeal is frivolous and is taken for the purpose of delay.”
He called the government’s action in the case an “administrative agency filibuster” designed to indefinitely sidetrack his earlier order.
The Brooklyn-based judge granted a short postponement of the order, giving government lawyers until noon Monday to file their appeal. The lawyers are expected to ask the Second US Circuit Court of Appeals to stay Korman’s order.
At issue is a long-running dispute over the availability of the morning-after pill. The Food and Drug Administration (FDA) decided years ago that the emergency contraceptive should be made widely available. That decision was overruled by Health and Human Services Secretary Kathleen Sebelius.
The judge has criticized the Sebelius reversal as politically motivated to avoid public criticism and political fallout.
In his ruling Korman cited the FDA’s own conclusion that the emergency contraceptive is safe and effective and that it “should be approved for nonprescription use for all females of child-bearing potential.”
Acting on that scientifically-based conclusion, the judge ruled in early April that women and girls who needed the emergency morning-after pill should be able to enter a drugstore and purchase it – without a prescription or an ID requirement – at the moment they most need it.
Last week, in response to his ruling, the FDA announced that the morning-after pill would be available on store shelves to those 15 and older. The prior cutoff had been 17.